Personal profile
Fingerprint
Dive into the research topics where Kullathorn Thephamongkhol is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
2% Lidocaine Spray vs. 2% Lidocaine Viscous for Head and Neck Cancer with Chemoradiation Mucositis
Upalananda, K., Prasartseree, T., Promsen, R., Sukamol, W., Sakpunpanom, P., Setakornnukul, J., Suiwongsa, B., Thephamongkhol, K., Rongthong, W. & Chantharasamee, J., Jul 2026, In: Journal of Pain and Symptom Management. 72, 1, p. 42-51 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of treatment outcomes between combined chemotherapy-radiation therapy (chemo-RT) and radiation therapy alone (RT) for intracranial germ cell tumors in adolescent and young adult patients (AYA)
Rongthong, W., Suntornpong, N., Thephamongkhol, K. & Treechairusame, T., Dec 2025, In: Discover Oncology. 16, 1, 391.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of treatment outcomes between combined chemotherapy-radiation therapy (chemo-RT) and radiation therapy alone (RT) for intracranial germ cell tumors in adolescent and young adult patients (AYA)
Rongthong, W., Suntornpong, N., Thephamongkhol, K. & Treechairusame, T., 25 Mar 2025, In: Discover Oncology. 16, 1, p. 391Research output: Contribution to journal › Article › peer-review
-
Early Results of Hypofractionated Chemoradiation in Cervical Cancer with 44 Gy/ 20 F vs 45 Gy/ 25 F: A Phase II, Open-Label, Randomised Controlled Trial (HYPOCx-iRex Trial)
Dankulchai, P., Prasartseree, T., Sittiwong, W., Thephamongkhol, K. & Nakkrasae, P., Oct 2025, In: Clinical Oncology. 46, 103907.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Efficacy and Safety of Short Intravenous Hydration for Preventing Nephrotoxicity From High-Dose Cisplatin: A Randomized, Open-Label, Phase II Trial
Jantarat, A., Thamlikitkul, L., Thephamongkhol, K., Setakornnukul, J., Phisalprapa, P., Kositamongkol, C., Srithongkul, T. & Ithimakin, S., 1 Jan 2025, In: JCO Global Oncology. 11, e2400515.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)